Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Anglaret

Showing results (51-60 of 161) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|August 31, 2013
Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Côte d'IvoireKévin Jean, Delphine Gabillard, Raoul Moh, et al.
Antiviral Therapy|August 3, 2007
The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'IvoireElena Losina, Yazdan Yazdanpanah, Sylvie Deuffic-Burban, et al.
Archives of Public Health = Archives Belges De Sante Publique|December 3, 2022
Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)Carine Grenier, Macha Loniewski, Mélanie Plazy, et al.
Antiviral Therapy|June 3, 2010
CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trialsYazdan Yazdanpanah, Lindsey L Wolf, Xavier Anglaret, et al.
AIDS Research and Human Retroviruses|July 22, 2009
Medium-term probability of success of antiretroviral treatment after early warning signs of treatment failure in West African adultsChristine Danel, Delphine Gabillard, Andre Inwoley, et al.
Cost Effectiveness and Resource Allocation : C/E|September 21, 2012
Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availabilityApril D Kimmel, Stephen C Resch, Xavier Anglaret, et al.
AIDS (London, England)|November 21, 2007
Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West AfricaRaoul Moh, Christine Danel, Eugène Messou, et al.
Plos One|October 27, 2010
Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'IvoireArmelle Pasquet, Eugène Messou, Delphine Gabillard, et al.
AIDS (London, England)|March 18, 2011
CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconvertersAlbert K Minga, Charlotte Lewden, Delphine Gabillard, et al.
BMC Infectious Diseases|December 31, 2013
Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008Yao Abo, Albert Minga, Hervé Menan, et al.
Pageof 17

Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|August 31, 2013
Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Côte d'IvoireKévin Jean, Delphine Gabillard, Raoul Moh, et al.
Antiviral Therapy|August 3, 2007
The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'IvoireElena Losina, Yazdan Yazdanpanah, Sylvie Deuffic-Burban, et al.
Archives of Public Health = Archives Belges De Sante Publique|December 3, 2022
Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)Carine Grenier, Macha Loniewski, Mélanie Plazy, et al.
Antiviral Therapy|June 3, 2010
CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trialsYazdan Yazdanpanah, Lindsey L Wolf, Xavier Anglaret, et al.
AIDS Research and Human Retroviruses|July 22, 2009
Medium-term probability of success of antiretroviral treatment after early warning signs of treatment failure in West African adultsChristine Danel, Delphine Gabillard, Andre Inwoley, et al.
Cost Effectiveness and Resource Allocation : C/E|September 21, 2012
Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availabilityApril D Kimmel, Stephen C Resch, Xavier Anglaret, et al.
AIDS (London, England)|November 21, 2007
Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West AfricaRaoul Moh, Christine Danel, Eugène Messou, et al.
Plos One|October 27, 2010
Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'IvoireArmelle Pasquet, Eugène Messou, Delphine Gabillard, et al.
AIDS (London, England)|March 18, 2011
CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconvertersAlbert K Minga, Charlotte Lewden, Delphine Gabillard, et al.
BMC Infectious Diseases|December 31, 2013
Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008Yao Abo, Albert Minga, Hervé Menan, et al.
Pageof 17